Single-Base Changes: Base Editing
Efficient A-to-G conversions with six stocked ABE8e mRNAs.
- Wild type and high-specificity V106W variants
- NGG, NGN, and NRN PAM options
- Editing shown in HEK293, iPSC, K562, and primary T cells
Aldevron, in partnership with IDT, offers base editor and prime editor mRNAs for precise genome editing without double-strand DNA breaks or donor DNA templates. Base editing makes efficient single-base conversions. Prime editing expands the range of edits to all base substitutions, small insertions, and deletions.
Looking for cGMP manufacturing of Base or Prime Editing mRNA? Reach out to us to learn more.
Efficient A-to-G conversions with six stocked ABE8e mRNAs.
PE Ultra mRNA was engineered for improved editing activity compared to PEmax.
Figure 1. Target adenine editing efficiency across cell types for ABE8e-Cas variant combinations. Target adenine conversion at the indicated genomic loci was measured in HEK293, iPSC, K562, and primary T cells using ABE8e editors paired with nCas9, nSpG, or nSPRY. Data from ABE8e-WT and ABE8e-V106W were combined due to comparable on-target editing efficiencies and are presented as mean ± SEM (N = 6 biological replicates; 3 WT and 3 V106W). Cells were nucleofected using the Lonza nucleofection system with 1,000ng of base editor mRNA in HEK293, K562, and primary T cells or 500ng in iPSCs. gRNA was delivered at 2 µM in HEK293, K562, and iPSCs and 4 µM in primary T cells. High levels of target base conversion were observed across diverse cell types and Cas variants.
Figure 1. Editing efficiency of PE Ultra and PEmax in HEK293 cells. PE Ultra and PEmax mRNA and Alt-R pegRNA (6 µM) targeting a broad panel of sites (all 6 bp insertions) were delivered by nucleofection into HEK293 cells using the Lonza Nucleofection® System. Genomic DNA (gDNA) was extracted 72 hours post-nucleofection and editing was assessed by NGS.
| Item No | Description | Purchase Option |
|---|---|---|
| 3840-0020 | ABE8e nCas9 mRNA, RG, 20 µg | |
| 3840-0100 | ABE8e nCas9 mRNA, RG, 100 µg | Buy Now |
| 3840-1 | ABE8e nCas9 mRNA, RG, 1 mg | Buy Now |
| 3841-0020 | ABE8e nSpG mRNA, RG, 20 µg | Buy Now |
| 3841-0100 | ABE8e nSpG mRNA, RG, 100 µg | Buy Now |
| 3841-1 | ABE8e nSpG mRNA, RG, 1 mg | Buy Now |
| 3842-0020 | ABE8e nSPRY mRNA, RG, 20 µg | Buy Now |
| 3842-0100 | ABE8e nSPRY mRNA, RG, 100 µg | Buy Now |
| 3842-1 | ABE8e nSPRY mRNA, RG, 1 mg | Buy Now |
| 3843-0020 | ABE8e-V106W nCas9 mRNA, RG, 20 µg | Buy Now |
| 3843-0100 | ABE8e-V106W nCas9 mRNA, RG, 100 µg | Buy Now |
| 3843-1 | ABE8e-V106W nCas9 mRNA, RG, 1 mg | Buy Now |
| 3844-0020 | ABE8e-V106W nSpG mRNA, RG, 20 µg | Buy Now |
| 3844-0100 | ABE8e-V106W nSpG mRNA, RG, 100 µg | Buy Now |
| 3844-1 | ABE8e-V106W nSpG mRNA, RG, 1 mg | Buy Now |
| 3845-0020 | ABE8e-V106W nSPRY mRNA, RG, 20 µg | Buy Now |
| 3845-0100 | ABE8e-V106W nSPRY mRNA, RG, 100 µg | Buy Now |
| 3845-1 | ABE8e-V106W nSPRY mRNA, RG, 1 mg | Buy Now |